Xoma Royalty Corporation (XOMA) - News Archive

In a dynamic landscape dominated by relentless competition, XOMA Royalty Corporation has made notable strides with the recent divestiture of its remaining Kinnate pipeline assets. This strategic move has potentially tra...

XOMA Royalty Expands Its Portfolio with Seralutinib, Secures Milestone Payment Amid Market ChallengesIn a significant move that underscores its commitment to shareholders, XOMA Corporation (NASDAQ: XOMA) has added Seral...

XOMA s Cash Infusion and Commitment to Shareholders Amidst Stock Performance ChallengesEMERYVILLE, Calif., June 12, 2024 - XOMA Corporation (NASDAQ: XOMA), a biotech royalty aggregator, recently received an $8.1 million...

In the first quarter of 2024, biotech company XOMA Corporation reported robust financial results and announced the U.S. Food and Drug Administration’s (FDA) approval of Day One s medical breakthrough OJEMDA (tovorafenib...

CSIMarket.com XOMA, a leading biotechnology company, has recently announced the addition of three first-in-category assets to its existing royalty and milestone portfolio. These assets encompass cutting-edge pharmaceuti...

brings you the latest development in the field of oncology, as XOMA Pharmaceuticals celebrates a significant milestone. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Day One Biopharmace...

XOMA, a leading biotech company in the Major Pharmaceutical Preparations industry, has recently announced a significant non-dilutive royalty capital solution to Talphera worth $8 million. This deal marks another milesto...

In the dynamic world of biotechnology, companies face constant challenges in developing innovative therapies and maintaining a robust stock performance. XOMA Corporation, a biotechnology firm based in Emeryville, Califo...

This move by XOMA comes after the company s Leverage Ratio fell to 0.17 due to net new borrowings of 16.69%. Although below the Xoma average Leverage Ratio, it is worth noting that 42 other companies within the industry...

In a recent press release by XOMA Corporation (XOMA), the San Francisco-based biotech company reaffirmed its dedication to its valued shareholders amidst the backdrop of a challenging stock performance. The press releas...

XOMA Corporation, a biotechnology company based in Emeryville, California, announced today that their Board of Directors has approved cash dividends for holders of XOMA s Series A and Series B Cumulative Preferred Stock...